1-7 of 7
Bernhard Wörmann
Close
Sort by
Journal Articles

Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1 -Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

Marius Bill, Jan-Niklas Eckardt, Christian Rausch, Klaus H Metzeler, Karsten Spiekermann, Sebastian Stasik, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Utz Krug, Bernhard Wörmann, Wolfgang Hiddemann, Dennis Görlich, Maria Cristina Sauerland, Björn Steffen, Hermann Einsele, Andreas Neubauer, Andreas Burchert, Kerstin Schaefer-Eckart, Wolfgang E. Berdel, Christoph Schliemann, Stefan W. Krause, Mathias Hanel, Maher Hanoun, Martin Kaufmann, Lars Fransecky, Jan Braess, Leo Ruhnke, Johannes Schetelig, Jan Moritz Middeke, Hubert Serve, Claudia D Baldus, Uwe Platzbecker, Carsten Müller-Tidow, Martin Bornhäuser, Tobias Herold, Christian Thiede, Christoph Röllig
Journal: Blood
Blood (2023) 142 (Supplement 1): 721.
https://doi.org/10.1182/blood-2023-186160
Published: 2023
Journal Articles

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

Klaus H. Metzeler, Tobias Herold, Maja Rothenberg-Thurley, Susanne Amler, Maria C. Sauerland, Dennis Görlich, Stephanie Schneider, Nikola P. Konstandin, Annika Dufour, Kathrin Bräundl, Bianka Ksienzyk, Evelyn Zellmeier, Luise Hartmann, Philipp A. Greif, Michael Fiegl, Marion Subklewe, Stefan K. Bohlander, Utz Krug, Andreas Faldum, Wolfgang E. Berdel, Bernhard Wörmann, Thomas Büchner, Wolfgang Hiddemann, Jan Braess, Karsten Spiekermann
Journal: Blood
Blood (2016) 128 (5): 686–698.
https://doi.org/10.1182/blood-2016-01-693879
Published: 2016
Includes: Supplemental data
Journal Articles

DNMT3A Mutations Associate with Shorter Survival and Modulate the Prognostic Impact of Mutated NPM1: an Analysis Based on Comprehensive Mutational Screening of 660 AML Patients Treated on German AML Cooperative Group (AMLCG) Trials

Klaus H. Metzeler, MD, Tobias Herold, MD, Maja Rothenberg-Thurley, PhD, Susanne Amler, Cristina Sauerland, Stephanie Schneider, PhD, Nikola P Konstandin, PhD, Annika Maria Dufour, PhD, Kathrin Bräundl, Bianka Ksienzyk, Evelyn Zellmeier, Luise Hartmann, MSc, Philipp A. Greif, MD, Michael Fiegl, MD, Marion S. Subklewe, MD, Stefan K. Bohlander, MD, Utz Krug, MD, Wolfgang E Berdel, MD, Bernhard Wörmann, MD, Thomas Büchner, MD, Andreas Faldum, PhD, Wolfgang Hiddemann, MD, Jan Braess, MD, Karsten Spiekermann, MD
Journal: Blood
Blood (2015) 126 (23): 3815.
https://doi.org/10.1182/blood.V126.23.3815.3815
Published: 2015
Journal Articles

Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG

Clinical Trials & Observations
Jan Braess, Karsten Spiekermann, Peter Staib, Andreas Grüneisen, Bernhard Wörmann, Wolf-Dieter Ludwig, Hubert Serve, Albrecht Reichle, Rudolf Peceny, Daniel Oruzio, Christoph Schmid, Xaver Schiel, Marcus Hentrich, Christina Sauerland, Michael Unterhalt, Michael Fiegl, Wolfgang Kern, Christian Buske, Stefan Bohlander, Achim Heinecke, Herrad Baurmann, Dietrich W. Beelen, Wolfgang E. Berdel, Thomas Büchner, Wolfgang Hiddemann
Journal: Blood
Blood (2009) 113 (17): 3903–3910.
https://doi.org/10.1182/blood-2008-07-162842
Published: 2009
Journal Articles

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

Klaus H. Metzeler, Manuela Hummel, Clara D. Bloomfield, Karsten Spiekermann, Jan Braess, Maria-Cristina Sauerland, Achim Heinecke, Michael Radmacher, Guido Marcucci, Susan P. Whitman, Kati Maharry, Peter Paschka, Richard A. Larson, Wolfgang E. Berdel, Thomas Büchner, Bernhard Wörmann, Ulrich Mansmann, Wolfgang Hiddemann, Stefan K. Bohlander, Christian Buske
Journal: Blood
Blood (2008) 112 (10): 4193–4201.
https://doi.org/10.1182/blood-2008-02-134411
Published: 2008
Includes: Supplemental data
Journal Articles

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Clinical Trials & Observations
Eva Hoster, Martin Dreyling, Wolfram Klapper, Christian Gisselbrecht, Achiel van Hoof, Hanneke C. Kluin-Nelemans, Michael Pfreundschuh, Marcel Reiser, Bernd Metzner, Hermann Einsele, Norma Peter, Wolfram Jung, Bernhard Wörmann, Wolf-Dieter Ludwig, Ulrich Dührsen, Hartmut Eimermacher, Hannes Wandt, Joerg Hasford, Wolfgang Hiddemann, Michael Unterhalt
Journal: Blood
Blood (2008) 111 (2): 558–565.
https://doi.org/10.1182/blood-2007-06-095331
Published: 2008
Includes: Supplemental data
Journal Articles

High Antileukemic Efficacy and Shortened Neutropenia of Dose-Dense Induction (Sequential-HAM Followed by Pegfilgrastim) in Primary Acute Myeloid Leukemia - Results of a Pilot Study of the German AML-CG.

Jan Braess, MD, PhD, Karsten Spiekermann, MD, PhD, Christian Buske, MD, PhD, Peter Staib, MD, PhD, Wolf-Dieter Ludwig, MD, PhD, Andreas Gruneisen, MD, Christa Sauerland, PhD, Michael Unterhalt, MD, PhD, Michael Fiegl, MD, Bernhard Wormann, MD, PhD, Wolfgang Kern, MD, PhD, Achim Heinicke, PhD, Wolfgang Berdel, MD, PhD, Thomas Büchner, MD, PhD, Wolfgang Hiddemann, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 295.
https://doi.org/10.1182/blood.V110.11.295.295
Published: 2007